HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Comes Out Sparkling As Judge Dismisses Colgate Complaint

This article was originally published in The Rose Sheet

Executive Summary

Colgate's failure to provide a consumer survey supporting its argument that ad claims for Procter & Gamble's Crest Whitestrips and Night Effects denigrate Colgate Simply White and Simply White Night appeared to resonate with a jury hearing Colgate-Palmolive v. Procter & Gamble

You may also be interested in...



Colgate Lawsuit Takes Aim At P&G Crest Tooth Whitening Ads

Colgate is seeking to block ads for Procter & Gamble's Crest Whitestrips andNight Effects and products, claiming the ads unfairly disparage its Simply White and Simply White Night Whitening Gels

Crest Whitestrips Ad Comparison To Simply White Gets Mixed NAD Review

Procter & Gamble's recent TV ad humorously comparing Crest Whitestrips to Colgate Simply White makes an adequately supported superior whitening claim but "falsely denigrates" the Colgate-Palmolive product, the National Advertising Division of the Council for Better Business Bureaus concludes in a recently-released review

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012378

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel